The prevention and treatment of tetanus in the burn patient.
D002056:Burns / Q000150:complications* / Q000382:microbiology; D003017:Clostridium tetani / Q000302:isolation & purification; D003646:Debridement; D003975:Diazepam / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D010348:Patient Care Team; D012131:Respiratory Insufficiency / Q000517:prevention & control; D013449:Sulfonamides / Q000627:therapeutic use; D013742:Tetanus / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D013743:Tetanus Antitoxin / Q000627:therapeutic use; D013745:Tetanus Toxoid / Q000627:therapeutic use; D014050:Toluene / Q000627:therapeutic use; D014946:Wound Infection / Q000517:prevention & control; D005719:gamma-Globulins / Q000627:therapeutic use
D013449:Sulfonamides; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D005719:gamma-Globulins; D014050:Toluene; D003975:Diazepam